Alkermes schizophrenia drug keeps weight gain side effect in check

Alkermes Plc's schizophrenia drug met its main goal of keeping in check a common side effect of antipsychotic medicines - weight gain - taking the company one step closer to a marketing approval for the treatment.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news